Back

Challenges for reaching LDL-C goals in high and very high risk patients.

29 August 2017 (12:45 - 12:55)
Organised by:
Congress Presentation Part of: Are we prepared to reduce LDL-cholesterol at any cost? Drug therapy Open Access ESC Congress 2017

About the speaker

Photo
Professor Lale Tokgozoglu

Hacettepe University, Ankara (Turkiye)

4 More presentations in this session

Presentation thumbnail
High potency statins and beyond: benefits of combination therapy.
Doctor M. Farnier (Dijon, FR)
Presentation thumbnail
Last step on the ladder: proprotein convertase subtilisin/kexin type 9 (PCSK9).
Professor L. Tokgozoglu (Ankara, TR)
Presentation thumbnail
Cost implications of misunderstanding statin intolerance.
Professor E. Stroes (Amsterdam, NL)
Presentation thumbnail
Conclusion - Are we prepared to reduce LDL-cholesterol at any cost?
Professor L. Tokgozoglu (Ankara, TR)

Access the full session

Session thumbnail
Are we prepared to reduce LDL-cholesterol at any cost?

The Event

Event poster

ESC Congress 2017

29 August 2017 12:45 CET
You may be interested in
thumbnail
Congress Presentation
The evolving need and challenges to reach LDL-c targets in high-risk patients
25 August 2023
thumbnail
Congress Presentation
Attainment of guideline recommended cholesterol goals in cardiovascular prevention results from a preventive cardio-rheuma clinic in norway
25 April 2024
thumbnail
Webinar
Post-ACS management of dyslipidaemia: tips and tricks from real world experiences
16 December 2020
thumbnail
Congress Presentation
The COR Lipid-Registry: The effectiveness of the strike early and strike strong strategy (SES) in patients with high cardiovascular risk
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources